Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

CGC-11047 studied in patients with AMD

Nov. 10, 2006

Lux licenses ciclosporin-eluting silicone matrix ocular implant from NIH

Nov. 9, 2006

MacuSight's proprietary sirolimus formulation begins phase I study in wet AMD

Nov. 6, 2006

TG-100801 for ocular diseases studied in phase I

Nov. 3, 2006

Recent PhotoBioChem patent describes new porphyrin derivatives for AMD

Oct. 30, 2006

Bayer and Regeneron to collaborate on VEGF Trap-Eye

Oct. 23, 2006

BVT-28949 begins phase II study for glaucoma

Oct. 18, 2006

Phase III trial of NOVA-22007 in vernal keratoconjunctivitis completes enrollment

Oct. 9, 2006

Santhera to develop SNT-MC17 for Leber's hereditary optic neuropathy

Oct. 2, 2006

L-90268: a novel prostanoid EP4 receptor agonist with ocular hypotensive activity

Sep. 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...